© Jabil Circuit Inc Electronics Production | July 06, 2018
The Healthcare supply chain needs a technology revolution
Think about the number of items you use in your daily life that are more than 20 years old. Most likely, your car, mobile devices and home appliances are all less than 20 years old.
In sharp contrast, many devices used in the medical industry, items that are meant to ensure people’s health and save lives, utilize 20-year-old technology. It’s time to transform the healthcare supply chain. Compared with other markets, like the high-tech industry, change has been gradual in the medical device field. Technology does not drive the medical device industry, proven therapy does. Therapy, paired with the requirements of a regulated industry create a pace of change that is inconsistent with the technology that exists in their products. The conservative approach to product development and launch constructed by regulating bodies like the U.S. Food and Drug Administration influence the pace of change and new releases to the market. This rigorous approval process is something we all can be thankful for. Significant cost for recertification and the sheer complexity of both the products and the process has discouraged manufacturers from reevaluating the healthcare supply chain. The Medical Device Industry and the Life Science Diagnostic Industry are like razor and razorblade industries. While you may continue to enhance the razor blades, this does not mean that you need to redesign the razor itself. The same thinking applies to healthcare. Redesigning existing products or launching new ones are not priorities if they are not needed in the market. Recertification risk, return on new product design investment and patient safety drive the extended product lifecycles to be at 10-15 years as commonplace. Unfortunately, that is no longer a luxury that can be afforded by the healthcare supply chain. Electronic component market conditions and corresponding shortages are affecting all types of industries — from mobile technology to aerospace and defense — and are starting to take a toll on the healthcare industry. Although these component families are commonly associated with the tech industry, they have played a prominent role in the medical market over the past decade. Ten years ago, Livemint predicted that medical devices would be the next big market for semiconductors, and other component devices, forecasting 12 percent annual growth. Two years later, ECN touted that semiconductor demands by the healthcare industry for diagnostic and monitoring devices were influencing semiconductor research. Now, everything from pacemakers to blood pressure monitors and other critical products rely on semiconductors along with other electronic components. This requirement will only grow with the focus on personalized medicine, the change in the point of care and connected health. Some of these components, which may cost as little as a few pennies a piece and rarely seemed worth a product redesign to future-proof them are now slowing and even shutting down production lines across industries due to low supply. As component supplier's prices were driven down following the last recession, many suppliers focused their investment and growth plans on newer, high-growth and high-margin components. Due to this transition and a few other factors, the supply of older generation products is not keeping up with demand, resulting in a supply shortage. Lead times for some of these products can stretch as long as a year, and in some cases, healthcare manufacturers cannot acquire the parts necessary to support production requirements. A New Healthcare Supply Chain Reality: The Past Can’t Dictate the Future Component shortages are not a new challenge for the healthcare industry. In the past, healthcare manufacturers have opted to simply pay higher premiums for parts or buy them in bulk and hold them on their balance sheets. However, the problem with this severe and unprecedented shortage is that there are fewer parts left to buy and hold in inventory and suppliers are driving old technology packages into end-of-life. This point tends to perplex some of our healthcare customers. They'll quickly point out that they clearly communicate their product needs in advance, so it is frustrating that component suppliers cannot deliver on some of these older generation product families. That may well be true, but the problem is that healthcare manufacturers are used to working with legacy parts, however, in the current environment some of these components will be harder and harder to procure. In large part it is basic economics. Industries such as automotive, mobility and network infrastructure drive a very large percentage of the overall electronics pie. In fact, a large percentage of the product’s cost of goods in automotive is electronics. Healthcare and diagnostic products are generally much lower volume in comparison and electronics are a much smaller percentage of the overall product’s cost of goods. Connected Health is Transforming the Healthcare Supply Chain There hasn’t been excessive need for products to be redesigned at a pace consistent with technology in the past, but connected health is changing the healthcare supply chain. This point is even more salient when you consider how fast products move in an Internet of Things (IoT) world. Big data and other emerging technologies are changing how patients are seen, where they experience care, how their information is managed, all while shortening the development and approval of new healthcare products. A few years ago, there were only a few connected health devices on the market. Today, there are hundreds. Healthcare is going through a transformation, which are lowering healthcare costs. The collision of proven therapies with the industry-driven need for new technology is driving healthcare manufacturers to reinvent how they defend current markets, capture new emerging markets and secure their commitments to shareholders. Healthcare manufacturers must drive a cultural change to include speed and technology as major drivers to their product strategies. This process becomes more complex when brands are incredibly committed and connected to patient safety. It creates an opportunity to innovate not only in therapy and devices but in the innovation process. New products must include plans for securing the healthcare supply chain. It’s time for the healthcare supply chain to move from being a technology laggard to a technology leader – or at least be somewhere in the middle. The Opportunity Cost of Delaying the Healthcare Supply Chain Given the nature of the industry up until now, today's turbulent environment is foreign to healthcare manufacturers. Times aren't changing, they have changed. Their strategies must not only include safe therapy and product development but must include how to manage the misalignment in product and technology lifecycles. In combination with the continued pressure on cost and the global growth in the need for affordable healthcare, there must be a plan for global manufacturing and supply chain. Healthcare manufacturers have lamented how expensive a redesign is, especially considering that it typically takes 18 months on average to bring a product to market. Unfortunately, this is the cost of doing business today. Every day we review the revenue impact to our customers, based on the impact of legacy technology shortages. In these conversations, focusing on the cost and risk of revenue and profit streams generally lead to a very simple answer. When coaching healthcare customers through this process, we try to help them quantify the value of a redesign or the opportunity cost of not doing a redesign. We discuss factors such as:
Author: Joe McBeth, Vice President, Global Supply Chain, Nypro Healthcare. This article was originally published on the Jabil Blog.
- the component lifecycle analysis and exposure
- impact from a perspective of immediacy and revenue loss
- how long they can manufacture with available components
- how much revenue they will miss based on the probable failures in the product’s supply pipelines
- the cost and time to redesign a product and secure the proper regulatory approvals before production can begin again
- the capabilities available or required for success
- Act today. Immediately perform a lifecycle analysis of your products and begin the design process to secure your revenue pipeline. In our healthcare portfolio, there is not one customer unaffected by the current market conditions.
- Do not choose a new component or set a project timeline without listening to your supply base. The electronics market moves faster and is more dynamic than most others. To ensure success, link your product development teams with supply chain teams. Make market conditions, supplier performance and preference as well as the technology roadmap a regular part of the discussion. Map your technology roadmaps against product lifecycles. These are foundational for success.
- Stay ahead of the technology curve. Don't be tempted and opt for slightly older, lower cost parts. If, for example, you choose a Wi-Fi component that is five or seven years into its lifecycle, that component will be seven or nine years old by the time your product goes to market. In addition to offering outdated technology in your product, you’ll likely be putting your product at risk since that part may soon become obsolete.
- Consider modular design. The FDA approval process certainly lengthens the redesign project timeline. To shorten this, opt for a modular design where possible. This may allow you to keep up with technology and only need to change the affected module. It won’t change the form fit or function of the product and will reduce or eliminate the regulatory requirement.
- Secure your future relevancy within the supply chain. It is no longer enough to have a working product, you must also have an effective and efficient healthcare supply chain. To remain relevant in the future you must continue to make investments that create speed and efficiency for both your customers and your suppliers. This requires continued development of a strong digital backbone. Relevancy is not simply tied to technology or digital infrastructure, it is also strongly tied to managing geographic cost and complexity. The world is a much smaller and more technologically capable place compared to 20 years ago. If you are buying raw printed circuit boards, capacitors or even metal machining that are manufactured in the United States, you are likely utilizing a more expensive opportunity from a supply chain that likely has not kept pace with some of the leading geographies.
- Follow the simple economic theory of "opportunity cost". Is it more valuable for you to continue to invest in the development of new manufacturing and supply chain solutions to remain relevant and efficient, or is it better for you to invest in developing and expanding your brand?
Author: Joe McBeth, Vice President, Global Supply Chain, Nypro Healthcare. This article was originally published on the Jabil Blog.
The advantage of Vantage - Garrett Wing tells the tale Nordson Asymtek's Garrett Wong gives us a rundown of the business year and also details the Vantage Advantage
Saki’s Eddie Ichiyama details a very successful business year Eddie ichiyama from Saki gave us an update on how 2019 has been for the company and also shared some details on the recent expansion in the Czech Republic.
The ripple effect of Enrico Krog Iversen while being an active part in creating one of the fastest growing robotics companies in modern time might have been enough for most people, that does not seem to have slowed down a certain Danish entrepreneur.
Yamaha's Ichiro Arimoto on the business year and the company's new ventures Evertiq had the opportunity to talk to Ichiro Arimoto, General Manager of Yamaha Motor Europe, about the business year and the company's new ventures.
Sponsored content by NCAB Group Benelux B.V.Failure is not an option for a PCB More than 30% of the Gerbers NCAB Group Benelux B.V. reviews, have problems. However, the PCB are integrated in key end-user product with more and more High Tech PCB. We are here to support you on the new technologies growth to maintain a high reliability and quality. Contact us to review it together.
Mycronic, Indium forge strategic partnership Indium Corporation has announced a strategic partnership with Sweden-based Mycronic, to develop no-clean and water soluble solder pastes for jetting applications.
SCHMID delivers PlasmaLine to Hofstetter PCB SCHMID announced it has installed the company’s first PlasmaLine comprising ICP etch & sputter deposition of its Korean JV SCHMID AVACO at Hofstetter PCB AG in Switzerland.
Cobot market to reach USD 9+ billion by 2025 A new report from Tractica is forecasting continued rapid growth for the global collaborative robot (cobot) market over the next few years, reaching revenue of USD 9.7 billion by 2025.
MixComm scores USD 8+ million in series B round New Jersey-based fabless semiconductor company MixComm has secured USD 8.6 million in series B funding led by existing investor, Kairos Ventures.
Sponsored content by SourcengineComponent Aggregators vs E-Commerce Marketplaces What is the difference between electronic component aggregators and a marketplace?
67% of a buyer’s journey is now done digitally. Learn how marketplaces emerged as full-cycle procurement platforms and challenged the traditional component aggregators.
SIA elects 2020 leadership The Semiconductor Industry Association (SIA) Board of Directors has elected ON Semiconductor CEO Keith Jackson as its 2020 Chair and Qorvo CEO Robert Bruggeworth as its 2020 Vice Chair.
Si wafer shipments recede for fourth straight quarter Worldwide silicon wafer area shipments slid for the fourth consecutive quarter of 2019, according to the SEMI Silicon Manufacturers Group (SMG) in its most recent quarterly analysis of the industry.
Decline in Q4 DRAM contract prices lessens as buying momentum recovers According to the latest analysis from the DRAMeXchange research division of TrendForce, Q4 DRAM ASP is as of yet undergoing a slight QoQ decline, but this decline has shrunk down to 5%.
Technica forms growth-focused equity fund San Jose-based Technica USA has reached an agreement on an equity investment centered on future growth for the global PCB fab and assembly supplier.
IHS Markit: 5G economy in the trillions by 2035 The IHS Markit 5G Economy Study, commissioned by Qualcomm Technologies Inc., is forecasting that 5G will generate USD 13.2 trillion in sales enablement by 2035.
ZEUS Battery partnering with Kruvand Associates ZEUS Battery Products and Texas-based Kruvand Associates Inc. have come to a formal agreement on a collaboration that began in January and covers Texas, Arkansas, Oklahoma, Louisiana, New Mexico, Arizona and Mexico.
EPP with a new owner The company announces that is has found itself an ideal buyer – Photonics Systems Group – a manufacturer of micro-materials processing machines. With this takeover, PSG is strengthening is operations in the electronics industry and also laying the foundation for further growth.
Volkswagen starts pre-production e-mobility plant in China The new plant of the SAIC VOLKSWAGEN joint venture has been completed. It is purely built for the production of all electric vehicles on Volkswagen’s Modular Electric Drive Matrix (MEB).
Sponsored content by EsemdaContract manufacturer Esemda opens new facility in Vilnius and expands EMS The new facility has been built with reserved space for future expansions. As Esemda constantly grows, it is of great importance to be able to rapidly increase production capacity in large volumes.
Kongsberg Maritime divests KM Contros GmbH Following a strategic review, Kongsberg Maritime AS (KM) has decided to divest KM Contros GmbH (Contros) to AML Oceanographic Ltd. (AML).
SUSS MicroTec adjusts outlook for fiscal year 2019 Based on the preliminary figures for the first nine months and the updated budget figures, SUSS MicroTec is substantiating its expectations for incoming orders, sales and earnings for the current fiscal year ending December 31, 2019.
GPV's revenues soars 130% Danish EMS provider, GPV Group, announces that the company generated revenues of DKK 2.2 billion in the first nine months of 2019, a 130% year-on-year improvement driven by the acquisition of Swiss company CCS at the end of 2018.
Sponsored content by Nordson ASYMTEKStart-to-finish conformal coating with reliability and efficiency Nordson ASYMTEK’s flexible, modular, Panorama™ S-Line delivers conformal coating process control in a space-saving footprint with overlapping line processes that minimize manufacturing floor space. This innovative, patent-pending line layout trims 50% of the line’s length by using the lower compartment in each piece of equipment for functional use. Combined with Nordson ASYMTEK’s global support, this complete conformal coating line delivers quality, product reliability, efficiency, and safety for all your conformal coating applications.
Former GM plant now Lordstown Motors Corp. General Motors’ shuttered Lordstown plant in Ohio, which closed in March, is now in the hands of an electric truck start-up that is looking to begin production in about a year.
Chinese chip maker to U.S. firms: don’t worry On Friday, the chairman of China’s top state-run semiconductor company, Tsinghua Unigroup, had some advice for U.S. chipmakers, saying they should “relax and sleep well,” with regard to China’s semiconductor development.
POET closes the sale of DenseLight POET Technologies, the designer and developer of the POET Optical Interposer and Photonic Integrated Circuits (PICs) for the data center and tele-communication markets, has successfully closed the sale of its DenseLight subsidiary in Singapore.
HAHN Group expands its footprint in the US via acquisition Factory automation and robotics solution provider, Hahn Group, has acquired REI Automation, Inc. The takeover is effective as of 01. November 2019.Load more news